Who
Alan S. Forman
Director
Company insider
Files Form 4 as: Director, JBG SMITH Properties; Director, Stemline Therapeutics; Director, Acadia Realty Trust.
In numbers
- Trades disclosed
- 27
- Buys
- 3
- Sells
- 0
- Bought
- $142K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 15 May 2006
- Last trade
- 30 Apr 2026
- Last filed
- 1 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Apr 2026filed 1 May 2026 | JBGS JBG SMITH Propertiesoption or derivative · REITs | SEC FORM 4 Code A | —18,036 | filing |
| 30 Apr 2026filed 1 May 2026 | JBGS JBG SMITH Propertiesoption or derivative · REITs | SEC FORM 4 Code A | —18,036 | filing |
| 24 Apr 2025filed 28 Apr 2025 | JBGS JBG SMITH Propertiesoption or derivative · REITs | SEC FORM 4 Code A | —18,438 | filing |
| 25 Apr 2024filed 29 Apr 2024 | JBGS JBG SMITH Propertiesoption or derivative · REITs | SEC FORM 4 Code A | —16,531 | filing |
| 4 May 2023filed 5 May 2023 | JBGS JBG SMITH Propertiesoption or derivative · REITs | SEC FORM 4 Code A | —18,141 | filing |
| 10 May 2022filed 11 May 2022 | JBGS JBG SMITH PropertiesREITs | SEC FORM 4 Bought | $74K3,000 at $24.67 | filing |
| 10 May 2022filed 11 May 2022 | JBGS JBG SMITH PropertiesREITs | SEC FORM 4 Bought | $24K1,000 at $23.85 | filing |
| 10 May 2022filed 11 May 2022 | JBGS JBG SMITH PropertiesREITs | SEC FORM 4 Bought | $24K1,000 at $23.75 | filing |
| 29 Apr 2022filed 3 May 2022 | JBGS JBG SMITH Propertiesoption or derivative · REITs | SEC FORM 4 Code A | —10,525 | filing |
| 29 Apr 2021filed 3 May 2021 | JBGS JBG SMITH Propertiesoption or derivative · REITs | SEC FORM 4 Code A | —3,800 | filing |
| 10 Jun 2020filed 10 Jun 2020 | Stemline Therapeuticsoption or derivative | SEC FORM 4 Code D | —34,000 | filing |
| 10 Jun 2020filed 10 Jun 2020 | Stemline Therapeuticsoption or derivative | SEC FORM 4 Code D | —24,000 | filing |
| 10 Jun 2020filed 10 Jun 2020 | Stemline Therapeutics | SEC FORM 4 Code U | —88,298 | filing |
| 30 Apr 2020filed 4 May 2020 | JBGS JBG SMITH Propertiesoption or derivative · REITs | SEC FORM 4 Code A | —3,523 | filing |
| 4 Dec 2019filed 6 Dec 2019 | Stemline Therapeutics | SEC FORM 4 Bought | $9,7301,000 at $9.73 | filing |
| 2 Dec 2019filed 4 Dec 2019 | Stemline Therapeutics | SEC FORM 4 Bought | $10K1,000 at $10.29 | filing |
| 25 Jun 2019filed 28 Jun 2019 | Stemline Therapeutics | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 2 May 2019filed 6 May 2019 | JBGS JBG SMITH Propertiesoption or derivative · REITs | SEC FORM 4 Code A | —2,756 | filing |
| 21 Jun 2018filed 22 Jun 2018 | Stemline Therapeutics | SEC FORM 4 Code A | —13,158 at $0.00 | filing |
| 3 May 2018filed 7 May 2018 | JBGS JBG SMITH Propertiesoption or derivative · REITs | SEC FORM 4 Code A | —2,577 | filing |
News
Hudson Pacific Properties (NYSE:HPP) versus JBG SMITH Properties (NYSE:JBGS) Head to Head AnalysisJBGS · themarketsdaily.com · 7 Oct 2026
0 headlines in the last 90 days name Alan S. Forman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.